May 12, 2008 12:00 PM, By JIM KAROLEFSKI

Product proliferation and consumer demand create challenges for retailers at the shelf where room must be made for new Rx-to-OTC items By: By JIM KAROLEFSKI

Rx-to-OTC switches in the stomach care category bring additional sales, but they can sometimes be hard for food retailers to digest, given restricted shelf space.

A potential new entry to watch is the heartburn treatment drug Zegerid, from Shering-Plough Corp., Kenilworth, N.J. The drug maker applied this year to the U.S. Food and Drug Administration for a new drug application for an OTC low-dose version.

This article is part of SN's Premium content and requires registration. If not already a member, subscribe to Supermarket News today! Your subscription includes:

• Full access to the website, including over a decade of archives.
• The print magazine, delivered weekly, plus the Refresh supplement every quarter.
• More in-depth coverage of the supermarket industry than any other source.
• Surveys and industry data.
• Insight and commentary from industry insiders.

Registered Users	Subscribe Now!
User Name: Password: Remember Me	SAVE with a print/online combo or online-only options.
Already a Print-Only Subscribers? Upgrade to access Supermarket News' premium online content. Call 866-834-1247 to include premium access as part of your subscription!